← All devices 
Clinical / medical-grade · Other · by Owlet
Owlet Dream Sock
The first FDA-cleared OTC medical-grade infant pulse-ox sock — real oxygen and pulse readings, no subscription.
November 2023Owlet Dream Sock
Maturing2 yr 7 mo old
API access: No Raw data access: Yes — restricted Open source: Community
Clinical value
74/100
De Novo OTC infant pulse oximeter
Empowerment
58/100
Own it, no subscription; closed app
Everyday value
60/100
Worn sock + base station
A sock that tracks a baby’s pulse rate and blood oxygen with medical-grade pulse oximetry — the first and only FDA-cleared (De Novo, OTC) smart baby monitor of its kind, validated across skin tones, with no subscription required.
What it measures
Pulse rate and blood-oxygen (SpO2) via a foot pulse oximeter, plus sleep/waking trends; alerts via a base station and app when readings leave preset ranges.
Regulatory status
FDA De Novo clearance (Nov 2023) as an over-the-counter, medical-grade pulse oximeter for healthy infants 1–18 months and 6–30 lbs. (The prescription BabySat is the separate medical version.)
Validation & accuracy
Clinically tested in home and hospital settings; SpO2 accuracy within ±3% of arterial blood-gas reference across all skin tones, under motion and rest.
Data control & export
Raw data: restricted — live readings and historical trends in the Owlet Dream App, shareable with a pediatrician, but no open export or API; data stays in Owlet’s app. API: none.
Wearability & battery
A soft fabric sock (sizes for growth) worn during sleep, paired with a bedside base station; rechargeable sensor.
Cost & access
One-time ~$299.99; no subscription required (optional Owlet360 adds insights). HSA/FSA-eligible.
Who it serves
Parents who want medical-grade pulse-ox reassurance for a healthy infant during sleep.
Who is left out or burdened
Pediatric-only and narrow age/weight window; proprietary app with no open export; not a diagnostic/SIDS-prevention device.
✓ Strengths
- First & only FDA-cleared (De Novo) OTC infant pulse oximeter
- Validated across all skin tones, under motion
- No subscription required; HSA/FSA-eligible
- Base-station alerts plus shareable trends
✕ Weaknesses
- Healthy infants only (1–18 months, 6–30 lbs)
- Closed app — no open export or API
- Not a diagnostic or SIDS-prevention device
- Pediatric-only niche
74
Why this clinical score. A De Novo OTC clearance for medical-grade infant pulse oximetry, validated across skin tones, places it high on the clinical axis for its niche.
58
Why this empowerment score. Own the device with no subscription and shareable trends, but a closed app with no export or API holds empowerment mid-range.
60
Why this everyday score. Comfortable sock plus base station for nightly use; a focused, single-purpose pediatric device.
Latest news
Reviews & coverage
Reviewers and parents praise the reassurance of overnight oxygen and heart-rate alerts for infants, now with an FDA-cleared medical mode. The cautions are false alarms, anxiety, and that it shouldn't replace safe-sleep practices.
Summary is a draft synthesis of public coverage, not an endorsement. Links open a search of each outlet.
Reddit communities
Independent user communities where this device (or its category) is discussed.
Get it · manuals & support
Draft profile · public-source review, June 2026 · scores describe direction and degree, not buying advice. News, links, and prices change — verify with the manufacturer. Image is representative.